Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration
- PMID: 27019408
- PMCID: PMC4809718
- DOI: 10.1371/journal.pgen.1005944
Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration
Abstract
Mutations in the glucosidase, beta, acid (GBA1) gene cause Gaucher's disease, and are the most common genetic risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB) excluding variants of low penetrance. Because α-synuclein-containing neuronal aggregates are a defining feature of PD and DLB, it is widely believed that mutations in GBA1 act by enhancing α-synuclein toxicity. To explore this hypothesis, we deleted the Drosophila GBA1 homolog, dGBA1b, and compared the phenotypes of dGBA1b mutants in the presence and absence of α-synuclein expression. Homozygous dGBA1b mutants exhibit shortened lifespan, locomotor and memory deficits, neurodegeneration, and dramatically increased accumulation of ubiquitinated protein aggregates that are normally degraded through an autophagic mechanism. Ectopic expression of human α-synuclein in dGBA1b mutants resulted in a mild enhancement of dopaminergic neuron loss and increased α-synuclein aggregation relative to controls. However, α-synuclein expression did not substantially enhance other dGBA1b mutant phenotypes. Our findings indicate that dGBA1b plays an important role in the metabolism of protein aggregates, but that the deleterious consequences of mutations in dGBA1b are largely independent of α-synuclein. Future work with dGBA1b mutants should reveal the mechanism by which mutations in dGBA1b lead to accumulation of protein aggregates, and the potential influence of this protein aggregation on neuronal integrity.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
The effect of mutant GBA1 on accumulation and aggregation of α-synuclein.Hum Mol Genet. 2019 Jun 1;28(11):1768-1781. doi: 10.1093/hmg/ddz005. Hum Mol Genet. 2019. PMID: 30615125
-
Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.Hum Mol Genet. 2018 Jun 1;27(11):1972-1988. doi: 10.1093/hmg/ddy105. Hum Mol Genet. 2018. PMID: 29579237 Free PMC article.
-
Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.Hum Mol Genet. 2017 Jul 15;26(14):2603-2615. doi: 10.1093/hmg/ddx120. Hum Mol Genet. 2017. PMID: 28520872
-
Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.Mov Disord. 2016 Nov;31(11):1610-1618. doi: 10.1002/mds.26802. Epub 2016 Sep 13. Mov Disord. 2016. PMID: 27619775 Free PMC article. Review.
-
The relationship between glucocerebrosidase mutations and Parkinson disease.J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10. J Neurochem. 2016. PMID: 26860875 Free PMC article. Review.
Cited by
-
Biochemical fractionation of human α-Synuclein in a Drosophila model of synucleinopathies.bioRxiv [Preprint]. 2024 Feb 13:2024.02.05.579034. doi: 10.1101/2024.02.05.579034. bioRxiv. 2024. PMID: 38370694 Free PMC article. Preprint.
-
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery.Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220381. doi: 10.1098/rstb.2022.0381. Epub 2024 Feb 19. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38368939 Free PMC article. Review.
-
Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation.bioRxiv [Preprint]. 2023 Dec 13:2023.12.13.571406. doi: 10.1101/2023.12.13.571406. bioRxiv. 2023. PMID: 38168223 Free PMC article. Preprint.
-
Autophagic dysfunction and gut microbiota dysbiosis cause chronic immune activation in a Drosophila model of Gaucher disease.PLoS Genet. 2023 Dec 21;19(12):e1011063. doi: 10.1371/journal.pgen.1011063. eCollection 2023 Dec. PLoS Genet. 2023. PMID: 38127816 Free PMC article.
-
Animal Models for the Study of Gaucher Disease.Int J Mol Sci. 2023 Nov 7;24(22):16035. doi: 10.3390/ijms242216035. Int J Mol Sci. 2023. PMID: 38003227 Free PMC article. Review.
References
-
- Rosenbloom BE, Weinreb NJ. Gaucher disease: a comprehensive review. Critical reviews in oncogenesis. 2013;18(3):163–75. . - PubMed
-
- Machaczka M, Rucinska M, Skotnicki AB, Jurczak W. Parkinson's syndrome preceding clinical manifestation of Gaucher's disease. Am J Hematol. 1999;61(3):216–7. Epub 1999/07/09. . - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
